protagonist-inc.com - PTGX Stock Quotes

The following quotes on GURU.Markets illustrate the price action of Protagonist Therapeutics (PTGX), which is valued at 130.95. Protagonist Therapeutics operates in the precision immunology segment, where development risks and pressure from corporate behemoths are extremely high. The business relies on the creation of peptide agents, outsourcing production to third-party firms to reduce costs while effectively utilizing contract centers to expand testing and maintaining full control over patents.

PTGX - protagonist-inc.com Price Rate Chart over the range 07/04/2022 - 11/14/2026

Protagonist Therapeutics Inc - analytical breakdowns and key metrics (PTGX)

- stock value and consensus price forecast:

Price Chart Protagonist Therapeutics|PTGX - Forecast Levels Chart

- issuer market value details:

Market Valuation Protagonist Therapeutics, Inc.|PTGX - Aggregate Business Value

- issuer book value statistics:

Book Value per Share Protagonist Therapeutics|PTGX - Book Value of Business|Market Cap to Net Assets Ratio protagonist-inc.com|PTGX - Total Business Assets

- debt and solvency information:

Debt to Equity Protagonist Therapeutics|PTGX - Long-Term Liabilities to Equity|Short-Term Debt to Capital Protagonist Therapeutics|PTGX - Aggregate Debt Obligations|Debts to Book Capitalization Protagonist Therapeutics Inc|PTGX - Company Long-Term Debts|Company Short-Term Debt Protagonist Therapeutics|Quick Liquidity protagonist-inc.com

- earnings and market ratios statistics:

PTGX - Net Income|Projected Future Earnings Protagonist Therapeutics|PTGX - P/E Multiple|Projected Price to Earnings Protagonist Therapeutics Inc|PTGX - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Protagonist|PTGX - Operating income before deduction of amortization|Earnings per share for the last twelve months Protagonist Therapeutics|PTGX - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months protagonist-inc.com|PTGX - Net earnings per share growth this year|Expected earnings per share growth for next year Protagonist Therapeutics

- revenue and sales details:

PTGX - Revenue and Sales Volume|Company Projected Revenue Protagonist Therapeutics Inc|PTGX - Market Cap to Revenue Ratio|Forward P/S Multiple Protagonist Therapeutics, Inc.

Fundamental valuation:protagonist-inc.com

Signature product of Protagonist Therapeutics, Inc.

Protagonist Therapeutics (PTGX) represents a specialized biotech ecosystem focused on peptide development. This daily price chart captures the asset's value at 130.95. This indicator reflects the final trade of the session, demonstrating a real-time market valuation without artificial smoothing. Price action here depends directly on milestone payments and expectations regarding the FDA verdict. The company's fundamental value remains binary until regulatory approval is obtained.

Analysis of competing companies